| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| United States Department of Veterans Affairs | 19 | 2016 | 307 | 2.180 |
Why?
|
| Health Services Research | 16 | 2005 | 209 | 1.590 |
Why?
|
| Veterans | 20 | 2015 | 904 | 1.200 |
Why?
|
| Informed Consent | 7 | 2003 | 127 | 0.950 |
Why?
|
| Research | 7 | 2011 | 214 | 0.930 |
Why?
|
| United States | 44 | 2016 | 7335 | 0.850 |
Why?
|
| Geriatric Assessment | 9 | 2006 | 107 | 0.740 |
Why?
|
| Alcoholic Intoxication | 3 | 2016 | 61 | 0.720 |
Why?
|
| Patient Education as Topic | 7 | 2015 | 424 | 0.700 |
Why?
|
| Delivery of Health Care | 4 | 2016 | 445 | 0.690 |
Why?
|
| Hospitals, Veterans | 17 | 2004 | 147 | 0.690 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2004 | 929 | 0.680 |
Why?
|
| Humans | 138 | 2016 | 68525 | 0.680 |
Why?
|
| Mammography | 3 | 2015 | 310 | 0.640 |
Why?
|
| Military Medicine | 3 | 2016 | 53 | 0.630 |
Why?
|
| Academic Medical Centers | 3 | 2016 | 281 | 0.630 |
Why?
|
| Health Policy | 3 | 2016 | 221 | 0.600 |
Why?
|
| Total Quality Management | 3 | 2000 | 45 | 0.560 |
Why?
|
| Infectious Disease Medicine | 1 | 2015 | 2 | 0.550 |
Why?
|
| Mass Screening | 12 | 1994 | 837 | 0.550 |
Why?
|
| Patient Compliance | 6 | 2015 | 402 | 0.540 |
Why?
|
| Fractures, Bone | 1 | 2016 | 132 | 0.530 |
Why?
|
| Cooperative Behavior | 5 | 2015 | 235 | 0.520 |
Why?
|
| Schools, Medical | 1 | 2016 | 157 | 0.500 |
Why?
|
| Physician-Patient Relations | 3 | 2015 | 261 | 0.500 |
Why?
|
| Leadership | 1 | 2016 | 135 | 0.490 |
Why?
|
| Disability Evaluation | 3 | 2015 | 298 | 0.490 |
Why?
|
| Carotid Arteries | 2 | 2013 | 110 | 0.490 |
Why?
|
| Brain Diseases | 2 | 2013 | 78 | 0.470 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 299 | 0.450 |
Why?
|
| Telephone | 4 | 2000 | 160 | 0.440 |
Why?
|
| Human Experimentation | 2 | 2002 | 19 | 0.440 |
Why?
|
| Cerebrovascular Disorders | 5 | 1994 | 182 | 0.440 |
Why?
|
| Ambulatory Care | 9 | 2005 | 339 | 0.430 |
Why?
|
| Persian Gulf Syndrome | 6 | 2005 | 27 | 0.420 |
Why?
|
| Clinical Competence | 6 | 2005 | 657 | 0.420 |
Why?
|
| Efficiency | 2 | 2011 | 49 | 0.420 |
Why?
|
| Health Services for the Aged | 4 | 2002 | 21 | 0.420 |
Why?
|
| Budgets | 1 | 2011 | 12 | 0.410 |
Why?
|
| Heart Diseases | 2 | 2010 | 276 | 0.400 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2011 | 29 | 0.400 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 467 | 0.400 |
Why?
|
| Digitalis Glycosides | 2 | 2010 | 5 | 0.390 |
Why?
|
| Digitalis | 2 | 2010 | 5 | 0.390 |
Why?
|
| Communication | 3 | 2010 | 329 | 0.380 |
Why?
|
| Blood Pressure Determination | 6 | 1992 | 149 | 0.380 |
Why?
|
| North Carolina | 16 | 1995 | 224 | 0.380 |
Why?
|
| Evidence-Based Medicine | 4 | 2010 | 438 | 0.380 |
Why?
|
| Politics | 1 | 2010 | 31 | 0.380 |
Why?
|
| Mass Media | 1 | 2010 | 29 | 0.370 |
Why?
|
| Faculty, Medical | 1 | 2011 | 110 | 0.370 |
Why?
|
| Male | 75 | 2016 | 37281 | 0.360 |
Why?
|
| History, 21st Century | 3 | 2016 | 126 | 0.360 |
Why?
|
| Teaching | 1 | 2011 | 169 | 0.350 |
Why?
|
| History, 20th Century | 3 | 2016 | 248 | 0.350 |
Why?
|
| Aged | 50 | 2006 | 14842 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 766 | 0.340 |
Why?
|
| Health Priorities | 2 | 1999 | 23 | 0.320 |
Why?
|
| Systems Analysis | 4 | 2000 | 33 | 0.320 |
Why?
|
| Blood Glucose | 5 | 1995 | 631 | 0.320 |
Why?
|
| Nursing Homes | 3 | 2006 | 54 | 0.310 |
Why?
|
| Female | 60 | 2015 | 38015 | 0.300 |
Why?
|
| Middle Aged | 43 | 2015 | 21119 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 1995 | 1085 | 0.290 |
Why?
|
| Quality of Life | 8 | 2005 | 1515 | 0.290 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2010 | 98 | 0.280 |
Why?
|
| Physical Examination | 5 | 1993 | 152 | 0.270 |
Why?
|
| Quality of Health Care | 4 | 1997 | 322 | 0.270 |
Why?
|
| Ethics, Medical | 2 | 1999 | 86 | 0.270 |
Why?
|
| Costs and Cost Analysis | 3 | 2002 | 193 | 0.270 |
Why?
|
| Activities of Daily Living | 9 | 2005 | 319 | 0.260 |
Why?
|
| Cost-Benefit Analysis | 6 | 2006 | 503 | 0.250 |
Why?
|
| Outpatient Clinics, Hospital | 6 | 2004 | 69 | 0.250 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2000 | 503 | 0.250 |
Why?
|
| Brain | 2 | 2013 | 2175 | 0.250 |
Why?
|
| Data Interpretation, Statistical | 3 | 2003 | 329 | 0.240 |
Why?
|
| Internship and Residency | 3 | 2016 | 596 | 0.240 |
Why?
|
| Education, Medical | 2 | 2015 | 147 | 0.240 |
Why?
|
| Drug Therapy, Combination | 3 | 1996 | 648 | 0.240 |
Why?
|
| Health Status | 4 | 1994 | 429 | 0.230 |
Why?
|
| Sample Size | 1 | 2003 | 79 | 0.230 |
Why?
|
| Health Services Needs and Demand | 3 | 1999 | 149 | 0.230 |
Why?
|
| Health Care Costs | 5 | 2006 | 346 | 0.230 |
Why?
|
| Diffusion of Innovation | 2 | 2000 | 102 | 0.220 |
Why?
|
| Information Services | 3 | 2002 | 22 | 0.220 |
Why?
|
| Hypertension | 9 | 1992 | 1531 | 0.220 |
Why?
|
| Vitamin B 12 Deficiency | 3 | 1994 | 17 | 0.220 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2000 | 77 | 0.220 |
Why?
|
| Health Behavior | 2 | 1998 | 458 | 0.210 |
Why?
|
| Patient Selection | 2 | 2004 | 592 | 0.210 |
Why?
|
| Emergency Service, Hospital | 3 | 2016 | 711 | 0.210 |
Why?
|
| Organizational Objectives | 5 | 2000 | 70 | 0.210 |
Why?
|
| Cardiology | 2 | 1993 | 140 | 0.210 |
Why?
|
| Erythropoietin | 1 | 2002 | 96 | 0.200 |
Why?
|
| Focus Groups | 1 | 2002 | 247 | 0.200 |
Why?
|
| Gulf War | 3 | 2010 | 22 | 0.200 |
Why?
|
| Health Services Accessibility | 4 | 2000 | 581 | 0.190 |
Why?
|
| Health Care Reform | 2 | 2000 | 62 | 0.190 |
Why?
|
| Drug Prescriptions | 3 | 1998 | 135 | 0.190 |
Why?
|
| Patient Discharge | 4 | 1992 | 294 | 0.190 |
Why?
|
| Drug Utilization Review | 2 | 2004 | 19 | 0.190 |
Why?
|
| Predictive Value of Tests | 9 | 1994 | 1465 | 0.190 |
Why?
|
| Philosophy, Medical | 1 | 2000 | 12 | 0.190 |
Why?
|
| Adult | 23 | 2015 | 21375 | 0.180 |
Why?
|
| Epidemiologic Methods | 1 | 2000 | 83 | 0.180 |
Why?
|
| Frail Elderly | 3 | 2005 | 31 | 0.180 |
Why?
|
| Prospective Studies | 15 | 2006 | 3702 | 0.180 |
Why?
|
| Granulomatosis with Polyangiitis | 2 | 1995 | 11 | 0.170 |
Why?
|
| Pharmacists | 2 | 1998 | 125 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 3 | 2010 | 772 | 0.170 |
Why?
|
| Internal Medicine | 3 | 1996 | 118 | 0.170 |
Why?
|
| Medicare | 2 | 2002 | 316 | 0.170 |
Why?
|
| Health Services | 4 | 2005 | 87 | 0.170 |
Why?
|
| Kidney Failure, Chronic | 1 | 2002 | 365 | 0.170 |
Why?
|
| Carotid Artery Diseases | 2 | 1989 | 83 | 0.160 |
Why?
|
| Patient-Centered Care | 1 | 1999 | 106 | 0.160 |
Why?
|
| Research Design | 6 | 2003 | 729 | 0.160 |
Why?
|
| Patient Readmission | 2 | 2000 | 267 | 0.160 |
Why?
|
| Clinical Trials as Topic | 8 | 2003 | 848 | 0.160 |
Why?
|
| Pharmaceutical Services | 1 | 1998 | 47 | 0.160 |
Why?
|
| Eligibility Determination | 3 | 1988 | 31 | 0.150 |
Why?
|
| Brain Ischemia | 2 | 1995 | 665 | 0.150 |
Why?
|
| Geriatrics | 6 | 2002 | 69 | 0.150 |
Why?
|
| Exercise | 5 | 2003 | 657 | 0.150 |
Why?
|
| Insurance Benefits | 1 | 1997 | 6 | 0.150 |
Why?
|
| Health Maintenance Organizations | 1 | 1997 | 22 | 0.150 |
Why?
|
| Zidovudine | 2 | 1994 | 27 | 0.150 |
Why?
|
| Vitamin B 12 | 3 | 1994 | 21 | 0.150 |
Why?
|
| Chronic Disease | 3 | 1999 | 1329 | 0.150 |
Why?
|
| Hypophosphatemia, Familial | 2 | 1994 | 2 | 0.150 |
Why?
|
| Birds | 1 | 2016 | 17 | 0.140 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1994 | 121 | 0.140 |
Why?
|
| Autoantibodies | 2 | 1995 | 434 | 0.140 |
Why?
|
| Pharmacology, Clinical | 1 | 1996 | 13 | 0.140 |
Why?
|
| Manikins | 2 | 1993 | 42 | 0.140 |
Why?
|
| Nose | 1 | 1996 | 36 | 0.140 |
Why?
|
| Sensitivity and Specificity | 7 | 1995 | 1753 | 0.140 |
Why?
|
| Time | 1 | 2015 | 57 | 0.140 |
Why?
|
| Heart Sounds | 1 | 1995 | 3 | 0.140 |
Why?
|
| Research Subjects | 3 | 2003 | 45 | 0.140 |
Why?
|
| Professional-Patient Relations | 1 | 1996 | 71 | 0.140 |
Why?
|
| Methicillin Resistance | 1 | 1996 | 45 | 0.140 |
Why?
|
| Hospital Departments | 1 | 1995 | 15 | 0.130 |
Why?
|
| Primary Nursing | 1 | 1995 | 1 | 0.130 |
Why?
|
| Observer Variation | 3 | 1996 | 330 | 0.130 |
Why?
|
| Decision Making, Organizational | 1 | 2015 | 23 | 0.130 |
Why?
|
| Counseling | 3 | 1998 | 279 | 0.130 |
Why?
|
| Staphylococcus aureus | 2 | 1996 | 175 | 0.130 |
Why?
|
| Follow-Up Studies | 10 | 1996 | 3256 | 0.130 |
Why?
|
| Social Responsibility | 2 | 1999 | 39 | 0.130 |
Why?
|
| Cost of Illness | 2 | 1993 | 204 | 0.130 |
Why?
|
| Neurology | 1 | 1995 | 43 | 0.130 |
Why?
|
| Consent Forms | 2 | 1992 | 4 | 0.130 |
Why?
|
| Probability | 3 | 1990 | 244 | 0.130 |
Why?
|
| Patient Participation | 2 | 1999 | 145 | 0.130 |
Why?
|
| Hospital Administration | 1 | 2015 | 43 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 109 | 0.130 |
Why?
|
| Referral and Consultation | 6 | 1992 | 383 | 0.130 |
Why?
|
| Cicatrix | 1 | 2015 | 60 | 0.120 |
Why?
|
| Sunburn | 1 | 1994 | 6 | 0.120 |
Why?
|
| Data Collection | 4 | 2000 | 420 | 0.120 |
Why?
|
| Decision Making | 6 | 2002 | 410 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 156 | 0.120 |
Why?
|
| Physician's Role | 1 | 2015 | 116 | 0.120 |
Why?
|
| Drug Utilization | 1 | 1994 | 119 | 0.120 |
Why?
|
| Ethanol | 3 | 1990 | 892 | 0.120 |
Why?
|
| Sunlight | 1 | 1994 | 59 | 0.120 |
Why?
|
| HIV Seropositivity | 1 | 1994 | 65 | 0.120 |
Why?
|
| Clinical Medicine | 1 | 1993 | 20 | 0.120 |
Why?
|
| Military Personnel | 3 | 2009 | 220 | 0.120 |
Why?
|
| Decision Support Techniques | 2 | 1993 | 191 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 1994 | 392 | 0.120 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1994 | 79 | 0.120 |
Why?
|
| Hepatitis B Vaccines | 1 | 1993 | 11 | 0.120 |
Why?
|
| Diagnostic Tests, Routine | 2 | 1993 | 51 | 0.120 |
Why?
|
| Hospital Units | 3 | 2005 | 21 | 0.110 |
Why?
|
| Papanicolaou Test | 1 | 1993 | 54 | 0.110 |
Why?
|
| Vaginal Smears | 1 | 1993 | 78 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 2 | 2005 | 177 | 0.110 |
Why?
|
| Hyperglycemia | 2 | 1992 | 158 | 0.110 |
Why?
|
| Teaching Materials | 1 | 1992 | 16 | 0.110 |
Why?
|
| Hepatitis B | 1 | 1993 | 42 | 0.110 |
Why?
|
| Regression Analysis | 5 | 2004 | 737 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 1993 | 138 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 1994 | 203 | 0.110 |
Why?
|
| Drug Evaluation | 1 | 1992 | 47 | 0.110 |
Why?
|
| Random Allocation | 9 | 2009 | 442 | 0.110 |
Why?
|
| Defensive Medicine | 2 | 1989 | 3 | 0.110 |
Why?
|
| Program Development | 1 | 1993 | 240 | 0.110 |
Why?
|
| Coronary Disease | 1 | 1994 | 358 | 0.110 |
Why?
|
| Aged, 80 and over | 11 | 1999 | 4843 | 0.110 |
Why?
|
| Cohort Studies | 7 | 2005 | 2356 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 1993 | 174 | 0.110 |
Why?
|
| Cerebral Infarction | 1 | 1992 | 103 | 0.100 |
Why?
|
| Mortality | 1 | 1992 | 162 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 1993 | 267 | 0.100 |
Why?
|
| Mouth Neoplasms | 1 | 1994 | 206 | 0.100 |
Why?
|
| Health Promotion | 2 | 1994 | 407 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 1993 | 285 | 0.100 |
Why?
|
| Movement | 1 | 1992 | 179 | 0.100 |
Why?
|
| Palpation | 1 | 1991 | 21 | 0.100 |
Why?
|
| Diagnosis | 1 | 1991 | 15 | 0.100 |
Why?
|
| Health Care Rationing | 2 | 2002 | 32 | 0.100 |
Why?
|
| Brachial Artery | 1 | 1991 | 34 | 0.100 |
Why?
|
| Biomarkers | 2 | 1995 | 1593 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 1990 | 303 | 0.100 |
Why?
|
| Risk Factors | 7 | 2000 | 5719 | 0.100 |
Why?
|
| Guideline Adherence | 2 | 2003 | 284 | 0.090 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 1990 | 62 | 0.090 |
Why?
|
| Science | 1 | 2010 | 15 | 0.090 |
Why?
|
| Obesity | 3 | 1994 | 1074 | 0.090 |
Why?
|
| Melanoma | 1 | 1994 | 335 | 0.090 |
Why?
|
| Medicine | 1 | 2010 | 51 | 0.090 |
Why?
|
| Benchmarking | 2 | 2000 | 91 | 0.090 |
Why?
|
| Social Support | 1 | 1993 | 423 | 0.090 |
Why?
|
| Drug Interactions | 3 | 1996 | 289 | 0.090 |
Why?
|
| Endarterectomy | 1 | 1989 | 22 | 0.090 |
Why?
|
| Models, Organizational | 2 | 2000 | 97 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 1994 | 375 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 1996 | 219 | 0.090 |
Why?
|
| Survival Analysis | 4 | 2002 | 714 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2000 | 693 | 0.090 |
Why?
|
| Epidemiology | 2 | 2000 | 14 | 0.090 |
Why?
|
| Prognosis | 5 | 1996 | 2093 | 0.090 |
Why?
|
| Drug Costs | 3 | 1994 | 87 | 0.090 |
Why?
|
| Malpractice | 1 | 1989 | 15 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2004 | 7028 | 0.090 |
Why?
|
| Automobile Driving | 1 | 1990 | 88 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 1993 | 560 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 142 | 0.080 |
Why?
|
| Depressive Disorder | 2 | 1990 | 621 | 0.080 |
Why?
|
| Wrist Injuries | 1 | 1988 | 9 | 0.080 |
Why?
|
| Motor Activity | 1 | 1992 | 621 | 0.080 |
Why?
|
| South Carolina | 1 | 2015 | 2750 | 0.080 |
Why?
|
| Ascites | 1 | 1988 | 38 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 1990 | 213 | 0.080 |
Why?
|
| Emergencies | 1 | 1988 | 107 | 0.080 |
Why?
|
| Pain | 3 | 2003 | 472 | 0.080 |
Why?
|
| Breast Neoplasms | 3 | 1998 | 1533 | 0.080 |
Why?
|
| Primary Health Care | 2 | 1993 | 702 | 0.080 |
Why?
|
| Decision Theory | 1 | 1987 | 1 | 0.080 |
Why?
|
| Patient Care Team | 5 | 2002 | 311 | 0.080 |
Why?
|
| Neoplasms | 3 | 2005 | 1660 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 1993 | 778 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 1994 | 1172 | 0.070 |
Why?
|
| Hospitalization | 6 | 2002 | 977 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2005 | 2077 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 1993 | 551 | 0.070 |
Why?
|
| Methylmalonic Acid | 3 | 1994 | 6 | 0.070 |
Why?
|
| Research Support as Topic | 3 | 2003 | 58 | 0.070 |
Why?
|
| Feedback | 2 | 2000 | 90 | 0.070 |
Why?
|
| HIV Infections | 1 | 1993 | 775 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 4 | 1991 | 219 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2005 | 68 | 0.070 |
Why?
|
| Age Factors | 5 | 2005 | 1860 | 0.060 |
Why?
|
| Women's Health | 2 | 1998 | 148 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 1995 | 105 | 0.060 |
Why?
|
| Infarction | 1 | 1984 | 17 | 0.060 |
Why?
|
| Mycoplasma Infections | 1 | 2004 | 40 | 0.060 |
Why?
|
| Doxycycline | 1 | 2004 | 49 | 0.060 |
Why?
|
| Compartment Syndromes | 1 | 1983 | 13 | 0.060 |
Why?
|
| Case Management | 1 | 2004 | 46 | 0.060 |
Why?
|
| Insulin | 1 | 1987 | 617 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2003 | 1039 | 0.060 |
Why?
|
| Muscular Diseases | 1 | 1983 | 41 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 1990 | 805 | 0.060 |
Why?
|
| Vision Disorders | 1 | 1984 | 94 | 0.060 |
Why?
|
| Bone Marrow | 2 | 1986 | 168 | 0.060 |
Why?
|
| Drug Approval | 1 | 2003 | 50 | 0.060 |
Why?
|
| Bias | 2 | 1996 | 148 | 0.060 |
Why?
|
| Warfare | 1 | 2003 | 58 | 0.060 |
Why?
|
| Disclosure | 2 | 1994 | 45 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2003 | 107 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2005 | 269 | 0.060 |
Why?
|
| Research Personnel | 2 | 2003 | 83 | 0.060 |
Why?
|
| Medication Errors | 1 | 2004 | 116 | 0.060 |
Why?
|
| Ethics | 1 | 2002 | 17 | 0.050 |
Why?
|
| Ethics Committees, Research | 1 | 2002 | 22 | 0.050 |
Why?
|
| Body Image | 2 | 1994 | 100 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 1994 | 2264 | 0.050 |
Why?
|
| Hematocrit | 1 | 2002 | 70 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 87 | 0.050 |
Why?
|
| Retina | 1 | 1984 | 252 | 0.050 |
Why?
|
| Public Policy | 1 | 2002 | 71 | 0.050 |
Why?
|
| Physicians | 2 | 1996 | 324 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 215 | 0.050 |
Why?
|
| Diet, Diabetic | 2 | 1994 | 14 | 0.050 |
Why?
|
| Schilling Test | 2 | 1994 | 3 | 0.050 |
Why?
|
| Reference Standards | 2 | 1992 | 115 | 0.050 |
Why?
|
| Prevalence | 3 | 1996 | 1609 | 0.050 |
Why?
|
| Long-Term Care | 2 | 1996 | 53 | 0.050 |
Why?
|
| Hospitals, University | 2 | 1992 | 169 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 1994 | 95 | 0.050 |
Why?
|
| Software | 1 | 2003 | 418 | 0.050 |
Why?
|
| Community Health Planning | 1 | 2000 | 19 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 2 | 1994 | 167 | 0.050 |
Why?
|
| Risk Management | 1 | 2000 | 37 | 0.050 |
Why?
|
| Managed Care Programs | 1 | 2000 | 45 | 0.050 |
Why?
|
| Organizational Innovation | 1 | 2000 | 55 | 0.050 |
Why?
|
| Organizational Policy | 1 | 2000 | 42 | 0.050 |
Why?
|
| Accreditation | 1 | 2000 | 72 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 742 | 0.050 |
Why?
|
| Pilot Projects | 2 | 1996 | 1341 | 0.050 |
Why?
|
| Family Practice | 2 | 1995 | 312 | 0.040 |
Why?
|
| Inflation, Economic | 1 | 1999 | 2 | 0.040 |
Why?
|
| Risk Assessment | 2 | 1999 | 2004 | 0.040 |
Why?
|
| Algorithms | 3 | 1990 | 1194 | 0.040 |
Why?
|
| Bone Marrow Diseases | 1 | 1979 | 3 | 0.040 |
Why?
|
| Staff Development | 1 | 1999 | 35 | 0.040 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 2 | 1995 | 10 | 0.040 |
Why?
|
| Personnel Selection | 1 | 1999 | 37 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 1999 | 59 | 0.040 |
Why?
|
| Mental Competency | 1 | 1999 | 29 | 0.040 |
Why?
|
| Arsenic | 1 | 1979 | 46 | 0.040 |
Why?
|
| Health Resources | 1 | 1999 | 76 | 0.040 |
Why?
|
| Truth Disclosure | 1 | 1999 | 48 | 0.040 |
Why?
|
| Seizures | 1 | 1981 | 279 | 0.040 |
Why?
|
| Animals | 1 | 2016 | 20877 | 0.040 |
Why?
|
| Survival Rate | 2 | 2005 | 1055 | 0.040 |
Why?
|
| Disabled Persons | 1 | 1999 | 94 | 0.040 |
Why?
|
| Choice Behavior | 1 | 1999 | 85 | 0.040 |
Why?
|
| Rehabilitation | 1 | 1998 | 29 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2000 | 285 | 0.040 |
Why?
|
| Drug Therapy | 1 | 1998 | 71 | 0.040 |
Why?
|
| Cost Allocation | 1 | 1997 | 4 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 1026 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2000 | 378 | 0.040 |
Why?
|
| Mental Health | 2 | 2002 | 278 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2004 | 1737 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 1994 | 112 | 0.040 |
Why?
|
| Incidence | 2 | 2003 | 1582 | 0.040 |
Why?
|
| Forecasting | 1 | 1998 | 277 | 0.040 |
Why?
|
| Attitude to Health | 2 | 1991 | 403 | 0.040 |
Why?
|
| Diastole | 2 | 1988 | 161 | 0.040 |
Why?
|
| Ultrasonography | 2 | 1988 | 453 | 0.040 |
Why?
|
| Age of Onset | 2 | 2009 | 188 | 0.040 |
Why?
|
| Health Surveys | 1 | 1998 | 488 | 0.030 |
Why?
|
| Heart Murmurs | 1 | 1995 | 6 | 0.030 |
Why?
|
| Community-Acquired Infections | 1 | 1996 | 46 | 0.030 |
Why?
|
| Cholesterol | 2 | 1994 | 331 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2003 | 7264 | 0.030 |
Why?
|
| Patient Simulation | 1 | 1995 | 64 | 0.030 |
Why?
|
| Role | 1 | 1994 | 25 | 0.030 |
Why?
|
| Radiography | 2 | 1994 | 572 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1994 | 54 | 0.030 |
Why?
|
| Physician Assistants | 2 | 1986 | 47 | 0.030 |
Why?
|
| Body Weight | 3 | 1991 | 554 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1994 | 94 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 1996 | 188 | 0.030 |
Why?
|
| Osteomalacia | 1 | 1994 | 8 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1994 | 120 | 0.030 |
Why?
|
| Folic Acid | 1 | 1994 | 121 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 1995 | 1139 | 0.030 |
Why?
|
| Value of Life | 1 | 1993 | 14 | 0.030 |
Why?
|
| Triglycerides | 1 | 1994 | 184 | 0.030 |
Why?
|
| Outpatients | 1 | 1994 | 127 | 0.030 |
Why?
|
| Warfarin | 1 | 1994 | 93 | 0.030 |
Why?
|
| Cross Infection | 1 | 1996 | 195 | 0.030 |
Why?
|
| Ticlopidine | 1 | 1994 | 118 | 0.030 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1993 | 14 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 1994 | 161 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2009 | 791 | 0.030 |
Why?
|
| Breast Self-Examination | 1 | 1993 | 4 | 0.030 |
Why?
|
| Physicians, Women | 1 | 1993 | 23 | 0.030 |
Why?
|
| Conflict of Interest | 1 | 1993 | 48 | 0.030 |
Why?
|
| Physical Fitness | 2 | 1991 | 117 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 1994 | 122 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 1994 | 209 | 0.030 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1992 | 14 | 0.030 |
Why?
|
| Inpatients | 1 | 1994 | 208 | 0.030 |
Why?
|
| Therapeutic Human Experimentation | 1 | 1992 | 6 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 507 | 0.030 |
Why?
|
| Risk-Taking | 1 | 1994 | 210 | 0.030 |
Why?
|
| Aspirin | 1 | 1994 | 295 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1993 | 136 | 0.030 |
Why?
|
| Catecholamines | 1 | 1992 | 73 | 0.030 |
Why?
|
| Homes for the Aged | 1 | 1992 | 16 | 0.030 |
Why?
|
| Cause of Death | 1 | 1993 | 241 | 0.030 |
Why?
|
| Surveys and Questionnaires | 3 | 1994 | 2798 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1993 | 567 | 0.030 |
Why?
|
| Alcoholism | 1 | 1981 | 1109 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1987 | 2323 | 0.030 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1991 | 3 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1994 | 954 | 0.030 |
Why?
|
| Organizations | 1 | 1991 | 16 | 0.030 |
Why?
|
| Heart Valve Diseases | 1 | 1992 | 123 | 0.030 |
Why?
|
| Recurrence | 1 | 1994 | 948 | 0.030 |
Why?
|
| Medical Staff, Hospital | 2 | 1988 | 44 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 1994 | 248 | 0.030 |
Why?
|
| Logistic Models | 1 | 1995 | 1419 | 0.020 |
Why?
|
| Societies, Medical | 1 | 1993 | 403 | 0.020 |
Why?
|
| Self Concept | 1 | 1991 | 132 | 0.020 |
Why?
|
| Behavioral Research | 1 | 1991 | 10 | 0.020 |
Why?
|
| X Chromosome | 1 | 1991 | 28 | 0.020 |
Why?
|
| Rickets | 1 | 1991 | 20 | 0.020 |
Why?
|
| Time Factors | 2 | 1993 | 4655 | 0.020 |
Why?
|
| Reagent Strips | 1 | 1990 | 2 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1992 | 291 | 0.020 |
Why?
|
| Skin | 1 | 1994 | 451 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1991 | 90 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 1991 | 117 | 0.020 |
Why?
|
| Acute Disease | 1 | 1992 | 658 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 1990 | 37 | 0.020 |
Why?
|
| Comprehension | 1 | 1991 | 71 | 0.020 |
Why?
|
| Social Behavior | 1 | 1991 | 164 | 0.020 |
Why?
|
| Psychological Tests | 1 | 1990 | 96 | 0.020 |
Why?
|
| Infant | 2 | 1994 | 2891 | 0.020 |
Why?
|
| Reference Values | 1 | 1991 | 579 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1995 | 1851 | 0.020 |
Why?
|
| Child, Preschool | 2 | 1994 | 3185 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2004 | 1046 | 0.020 |
Why?
|
| Auscultation | 1 | 1988 | 4 | 0.020 |
Why?
|
| Hospitals | 1 | 1991 | 265 | 0.020 |
Why?
|
| Plethysmography | 1 | 1988 | 17 | 0.020 |
Why?
|
| Jurisprudence | 1 | 1988 | 11 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 1988 | 57 | 0.020 |
Why?
|
| Lung | 1 | 1994 | 849 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1994 | 807 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 1990 | 183 | 0.020 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1988 | 4 | 0.020 |
Why?
|
| Erythrocyte Indices | 1 | 1988 | 9 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 1989 | 109 | 0.020 |
Why?
|
| Medical History Taking | 1 | 1988 | 94 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 1987 | 5 | 0.020 |
Why?
|
| Malonates | 1 | 1987 | 4 | 0.020 |
Why?
|
| Heart Rate | 4 | 1991 | 568 | 0.020 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 1987 | 5 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 1990 | 253 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1988 | 100 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 1987 | 45 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 1987 | 36 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 1988 | 208 | 0.020 |
Why?
|
| Anemia | 1 | 1988 | 104 | 0.020 |
Why?
|
| Dementia | 2 | 1987 | 158 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 1987 | 40 | 0.020 |
Why?
|
| Insurance, Health | 1 | 1988 | 200 | 0.020 |
Why?
|
| Nurse Clinicians | 1 | 1986 | 20 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1987 | 60 | 0.020 |
Why?
|
| Systole | 1 | 1986 | 149 | 0.020 |
Why?
|
| Deoxyuridine | 1 | 1986 | 8 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 1986 | 26 | 0.020 |
Why?
|
| Leukemia | 1 | 1987 | 117 | 0.020 |
Why?
|
| Selection Bias | 1 | 2005 | 23 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 1985 | 38 | 0.020 |
Why?
|
| Causality | 1 | 2005 | 81 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 1994 | 1032 | 0.020 |
Why?
|
| Private Sector | 1 | 2005 | 18 | 0.020 |
Why?
|
| Child | 2 | 1994 | 6400 | 0.020 |
Why?
|
| Public Health Practice | 1 | 2005 | 23 | 0.020 |
Why?
|
| Adolescent | 3 | 1994 | 8903 | 0.020 |
Why?
|
| Aging | 1 | 1991 | 911 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1986 | 175 | 0.020 |
Why?
|
| Mycoplasma | 1 | 2004 | 10 | 0.020 |
Why?
|
| Photosensitivity Disorders | 1 | 2004 | 7 | 0.020 |
Why?
|
| Plants, Toxic | 1 | 1984 | 33 | 0.020 |
Why?
|
| Motivation | 1 | 1988 | 561 | 0.020 |
Why?
|
| Palliative Care | 1 | 1987 | 271 | 0.020 |
Why?
|
| Nausea | 1 | 2004 | 47 | 0.020 |
Why?
|
| Private Practice | 1 | 1984 | 19 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 1984 | 43 | 0.020 |
Why?
|
| Visual Fields | 1 | 1984 | 41 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 2004 | 15 | 0.020 |
Why?
|
| Indian Ocean | 1 | 2003 | 8 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 150 | 0.010 |
Why?
|
| Medical Records | 1 | 1984 | 121 | 0.010 |
Why?
|
| Heart Failure | 2 | 2000 | 1179 | 0.010 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2004 | 148 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 563 | 0.010 |
Why?
|
| Fatigue | 1 | 2003 | 132 | 0.010 |
Why?
|
| Depression | 1 | 1989 | 942 | 0.010 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2000 | 20 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1981 | 107 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2003 | 342 | 0.010 |
Why?
|
| Electron Probe Microanalysis | 1 | 1979 | 16 | 0.010 |
Why?
|
| Body Mass Index | 2 | 1991 | 866 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1995 | 95 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1992 | 51 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1991 | 40 | 0.010 |
Why?
|
| Knee | 1 | 1991 | 17 | 0.010 |
Why?
|
| Muscles | 1 | 1991 | 158 | 0.010 |
Why?
|
| Wrist | 1 | 1991 | 24 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1991 | 249 | 0.010 |
Why?
|
| Personality Inventory | 1 | 1989 | 196 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1988 | 14 | 0.010 |
Why?
|
| Psychiatry | 1 | 1989 | 112 | 0.000 |
Why?
|
| Exercise Test | 1 | 1989 | 242 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1989 | 216 | 0.000 |
Why?
|
| Indicator Dilution Techniques | 1 | 1987 | 8 | 0.000 |
Why?
|
| Deuterium | 1 | 1987 | 10 | 0.000 |
Why?
|
| Blood Pressure | 2 | 1984 | 1447 | 0.000 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1987 | 6 | 0.000 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1987 | 59 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1989 | 222 | 0.000 |
Why?
|
| Placebos | 1 | 1987 | 195 | 0.000 |
Why?
|
| Urinary Incontinence | 1 | 1987 | 67 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1989 | 253 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1989 | 782 | 0.000 |
Why?
|
| Meningism | 1 | 1985 | 1 | 0.000 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1985 | 4 | 0.000 |
Why?
|
| Syphilis Serodiagnosis | 1 | 1985 | 6 | 0.000 |
Why?
|
| Neurosyphilis | 1 | 1985 | 7 | 0.000 |
Why?
|
| Cryptococcus neoformans | 1 | 1985 | 24 | 0.000 |
Why?
|
| Cerebrospinal Fluid | 1 | 1985 | 23 | 0.000 |
Why?
|
| Meningitis | 1 | 1985 | 23 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1987 | 799 | 0.000 |
Why?
|
| Mycoses | 1 | 1985 | 60 | 0.000 |
Why?
|
| Pulmonary Heart Disease | 1 | 1984 | 3 | 0.000 |
Why?
|
| Digoxin | 1 | 1984 | 24 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1987 | 384 | 0.000 |
Why?
|
| Diuretics | 1 | 1984 | 96 | 0.000 |
Why?
|
| Glucose | 1 | 1985 | 307 | 0.000 |
Why?
|
| Consumer Behavior | 1 | 1983 | 68 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1987 | 1070 | 0.000 |
Why?
|